Technical Advance: Immunophenotypical characterization of human neutrophil differentiation

Journal of Leukocyte Biology

Volumn 90, Issue 3, 2011, Pages 629-634

  Mora Jensen, Helena ^a   Jendholm, Johan ^a   Fossum, Anna ^a   Porse, Bo ^a   Borregaad, Niels ^a   Theilgaard Mönch, Kim ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Differentiation pathway; Flow cytometry; Granulocytes; Human bone marrow; Myeloid differentiation

Indexed keywords

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; NEUTROPHIL; PRIORITY JOURNAL; PROMYELOCYTE; VALIDATION PROCESS;

BLOTTING, WESTERN; BONE MARROW; CELL DIFFERENTIATION; CELL LINE; CELL SEPARATION; FLOW CYTOMETRY; GRANULOCYTE PRECURSOR CELLS; GRANULOCYTES; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; MYELOID CELLS; MYELOID PROGENITOR CELLS; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 80052364253     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0311123     Document Type: Article

References (28)

1. Theilgaard-Mönch, K., Jacobsen, L. C., Borup, R., Rasmussen, T., Bjerregaard, M. D., Nielsen, F. C., Cowland, J. B., Borregaard, N. (2005) The transcriptional program of terminal granulocytic differentiation. Blood 105, 1785-1796.
2. Theilgaard-Mönch, K., Porse, B. T., Borregaard, N. (2006) Systems biology of neutrophil differentiation and immune response. Curr. Opin. Immunol. 18, 54-60.
3. Borregaard, N., Sorensen, O. E., Theilgaard-Monch, K. (2007) Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 28, 340-345.
4. Borregaard, N. (2010) Neutrophils, from marrow to microbes. Immunity 33, 657-670.
5. Theilgaard-Mönch, K., Knudsen, S., Follin, P., Borregaard, N. (2004) The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing. J. Immunol. 172, 7684-7693.
6. Theilgaard-Mönch, K., Jacobsen, L. C., Nielsen, M. J., Rasmussen, T., Udby, L., Gharib, M., Arkwright, P. D., Gombart, A. F., Calafat, J., Moestrup, S. K., Porse, B. T., Borregaard, N. (2006) Haptoglobin is synthesized during granulocyte differentiation, stored in specific granules, and released by neutrophils in response to activation. Blood 108, 353-361.
7. Theilgaard-Mönch, K., Jacobsen, L. C., Rasmussen, T., Niemann, C. U., Udby, L., Borup, R., Gharib, M., Arkwright, P. D., Gombart, A. F., Calafat, J., Porse, B. T., Borregaard, N. (2005) Highly glycosylated {α}1-acid glycoprotein is synthesized in myelocytes, stored in secondary granules, and released by activated neutrophils. J. Leukoc. Biol. 78, 462-470.
8. Collins, S. J. (1987) The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70, 1233-1244.
9. Lanotte, M., Martin-Thouvenin, V., Najman, S., Balerini, P., Valensi, F., Berger, R. (1991) NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77, 1080-1086.
10. Khanna-Gupta, A., Kolibaba, K., Zibello, T. A., Berliner, N. (1994) NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression. Blood 84, 294-302.
11. Le Cabec, V., Cowland, J. B., Calafat, J., Borregaard, N. (1996) Targeting of proteins to granule subsets is determined by timing and not by sorting: The specific granule protein NGAL is localized to azurophil granules when expressed in HL-60 cells. Proc. Natl. Acad. Sci. USA 93, 6454-6457.
12. Arnljots, K., Sorensen, O., Lollike, K., Borregaard, N. (1998) Timing, targeting and sorting of azurophil granule proteins in human myeloid cells. Leukemia 12, 1789-1795.
13. Faurschou, M., Kamp, S., Cowland, J. B., Udby, L., Johnsen, A. H., Calafat, J., Winther, H., Borregaard, N. (2005) Prodefensins are matrix proteins of specific granules in human neutrophils. J. Leukoc. Biol. 78, 785-793.
14. Link, K. A., Chou, F. S., Mulloy, J. C. (2010) Core binding factor at the crossroads: determining the fate of the HSC. J. Cell. Physiol. 222, 50-56.
15. Tenen, D. G., Hromas, R., Licht, J. D., Zhang, D. E. (1997) Transcription factors, normal myeloid development, and leukemia. Blood 90, 489-519.
16. Tenen, D. G. (2003) Disruption of differentiation in human cancer: AML shows the way. Nat. Rev. Cancer 3, 89-101.
17. D'Alo, F., Johansen, L. M., Nelson, E. A., Radomska, H. S., Evans, E. K., Zhang, P., Nerlov, C., Tenen, D. G. (2003) The amino terminal and E2F interaction domains are critical for C/EBP α-mediated induction of granulopoietic development of hematopoietic cells. Blood 102, 3163-3171.
18. Nerlov, C. (2007) The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 17, 318-324.
19. Khanna-Gupta, A., Zibello, T., Sun, H., Lekstrom-Himes, J., Berliner, N. (2001) C/EBP ε mediates myeloid differentiation and is regulated by the CCAAT displacement protein (CDP/cut). Proc. Natl. Acad. Sci. USA 98, 8000-8005.
20. Yamanaka, R., Barlow, C., Lekstrom-Himes, J., Castilla, L. H., Liu, P. P., Eckhaus, M., Decker, T., Wynshaw-Boris, A., Xanthopoulos, K. G. (1997) Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/ enhancer binding protein ε-deficient mice. Proc. Natl. Acad. Sci. USA 94, 13187-13192.
21. Lekstrom-Himes, J. A. (2001) The role of C/EBP(ε) in the terminal stages of granulocyte differentiation. Stem Cells 19, 125-133.
22. Soucek, L., Evan, G. I. (2010) The ups and downs of Myc biology. Curr. Opin. Genet. Dev. 20, 91-95.
23. van Riggelen, J., Yetil, A., Felsher, D. W. (2010) MYC as a regulator of ribosome biogenesis and protein synthesis. Nat. Rev. Cancer 10, 301-309.
24. Cowland, J. B., Borregaard, N. (1999) Isolation of neutrophil precursors from bone marrow for biochemical and transcriptional analysis. J. Immunol. Methods 232, 191-200.
25. Marstrand, T. T., Borup, R., Willer, A., Borregaard, N., Sandelin, A., Porse, B. T., Theilgaard-Mönch, K. (2010) A conceptual framework for the identification of candidate drugs and drug targets in acute promyelocytic leukemia. Leukemia 24, 1265-1275.
26. Klein, C. (2009) Molecular basis of congenital neutropenia. Haematologica 94, 1333-1336.
27. Berliner, N. (2008) Lessons from congenital neutropenia: 50 years of progress in understanding myelopoiesis. Blood 111, 5427-5432.
28. Dale, D. C., Link, D. C. (2009) The many causes of severe congenital neutropenia. N. Engl. J. Med. 360, 3-5.